Research from the University of Oklahoma reveals that a naturally occurring gut molecule, indole, can dramatically lower the chance of fatty liver disease in the children of mothers who consume a high‑fat, high‑sugar diet during pregnancy and nursing.
Why Indole Matters
Indole is produced when beneficial gut bacteria break down the amino acid tryptophan, which is abundant in foods such as turkey, nuts, and seeds. By supplementing pregnant and lactating mice with indole, scientists observed healthier livers, reduced weight gain, and steadier blood‑sugar levels in the next generation—even after the pups were later exposed to a Western‑style diet.
Connecting the Microbiome to Childhood MASLD
Metabolic‑associated steatotic liver disease (MASLD) affects roughly 30 % of obese children and about 10 % of those with a normal weight. The condition often remains silent until liver‑related symptoms appear, making early prevention crucial. The Oklahoma team, led by Dr. Jed Friedman and Dr. Karen Jonscher, explored whether the maternal microbiome can shape a child’s risk.
In the study, female mice received a high‑fat, high‑sugar diet throughout gestation and lactation. A subset also received indole. After weaning, the offspring were first fed a regular chow, then switched to a Western diet to trigger liver fat accumulation.
Protective Outcomes Observed
Offspring whose mothers took indole displayed several benefits:
- Smaller, healthier livers with fewer fat deposits
- Lower overall body weight
- More stable glucose levels
- Reduced size of fat cells
Biochemical analysis showed activation of the gut’s aryl hydrocarbon receptor (AHR) pathway, a known defender against metabolic stress. Importantly, harmful long‑chain ceramides did not increase, while protective very‑long‑chain ceramides rose.
Microbiome Transfer Confirms the Role of Gut Bacteria
When gut microbes from indole‑protected pups were transplanted into other mice that had not received indole, those recipients also showed reduced liver damage. This experiment underscores that the protective effect resides within the microbial community itself.
What This Means for Human Health
Although the findings come from animal models, they suggest that improving a mother’s gut microbiome—perhaps through diet, probiotics, or targeted compounds like indole—could be a viable strategy to curb the rising tide of pediatric MASLD. At present, weight loss remains the only proven therapy for children with established disease, and no medication has earned approval.
Future human studies will be needed, but the data encourage a shift toward early, microbiome‑focused interventions rather than attempting to reverse liver damage after it has taken hold.